Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder.

导出 LinkOut

翻译打印收藏纠错

第一作者： Amber N,Edinoff

第一单位： Department of Psychiatry and Behavioral Medicine, Louisiana State University Health Science Center Shreveport, Shreveport, LA, United States.

作者： Amber N,Edinoff ^[1] ; Haseeb A,Akuly ^[1] ; John H,Wagner ^[1] ; Megan A,Boudreaux ^[2] ; Leah A,Kaplan ^[2] ; Shadman,Yusuf ^[2] ; Elisa E,Neuchat ^[3] ; Elyse M,Cornett ^[4] ; Andrea G,Boyer ^[5] ; Adam M,Kaye ^[6] ; Alan D,Kaye ^[4]

作者单位： Department of Psychiatry and Behavioral Medicine, Louisiana State University Health Science Center Shreveport, Shreveport, LA, United States. ^[1] School of Medicine, Louisiana State University Health Shreveport, Shreveport, LA, United States. ^[2] School of Medicine, Florida International University, Miami, FL, United States. ^[3] Department of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA, United States. ^[4] Family Psychiatry and Psychology Associates, Cary, NC, United States. ^[5] Thomas J. Long School of Pharmacy and Health Sciences, Department of Pharmacy Practice, University of the Pacific, Stockton, CA, United States. ^[6]

关键词 ADHD neuropsychiatric disorder non-stimulant pediatrics serotonin-norepinephrine modulating agent viloxazine

DOI 10.3389/fpsyt.2021.789982

PMID 34975586

发布时间 2022-01-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in psychiatry

2021年12卷

789982页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder.

Frontiers in psychiatry

相似文献

Frontiers in psychiatry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder.

Frontiers in psychiatry

相似文献

Frontiers in psychiatry

相关期刊

检索历史清除